ARAZLO
ARAZLO
Approved
DIN Number
02517868
Drug Class
Human
Market Date
Sep 16, 2021
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02517868
AIG Number0133047003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D05AX05 TAZAROTENE
Product Specifications
Dosage FormLotion
Route of AdministrationTopical
AHFS Classification84:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TAZAROTENEActive
Strength: 0.045 % / W/W
Monograph: TAZAROTENE